Jazz Pharma's decision to revoke U.S. patent for rival narcolepsy drug

Published Date: 02 Mar 2023

A U.S. court on Friday ordered Jazz Pharmaceuticals to revoke its patents related to its flagship narcolepsy drug Xyrem from the FDA-approved brand name drug after winning a case against Avadel foe CNS Pharmaceuticals.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Chemo-Free Quadruplet Shows Promise as DLBCL's First Therapy.

2.

Asandeutertinib Tops Osimertinib for NSCLC With Brain Mets

3.

Study finds 20 minutes of mindful breathing can rapidly reduce intensity of cancer pain

4.

GuCS: Genitourinary Cancers Symposium

5.

Hydroxyurea Shows Some Benefits in Milder Sickle Cell Disease


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot